Level 3 (LVLT) Expands Relationship with ImClone (IMCL)
Up)
Earlier, Level 3 Communications, Inc. (NASDAQ: LVLT) today announced that it is expanding the communications services it provides ImClone Systems (Nasdaq: IMCL), a global biopharmaceutical company that is a wholly owned subsidiary of Eli Lilly and Company.
Under the contract, Level 3 - which currently provides data transport services to ImClone - will deliver colocation, Internet access and Internet-based private network services to ImClone's locations in New York City; Branchburg, N.J.; Bridgewater, N.J.; and Heidelberg, Germany, as well as ImClone's North American data center in Newark, N.J., and European data center in Frankfurt, Germany. To deliver these services, Level 3 will expand its fiber network to directly connect to ImClone's two New Jersey locations and the NYC location.
Under the contract, Level 3 - which currently provides data transport services to ImClone - will deliver colocation, Internet access and Internet-based private network services to ImClone's locations in New York City; Branchburg, N.J.; Bridgewater, N.J.; and Heidelberg, Germany, as well as ImClone's North American data center in Newark, N.J., and European data center in Frankfurt, Germany. To deliver these services, Level 3 will expand its fiber network to directly connect to ImClone's two New Jersey locations and the NYC location.
You May Also Be Interested In
- DISH Network (DISH) Sued by Networks for 'Commercial Skipping' Feature
- Icahn's Letter to the Chesapeake (CHK) Board: Says Directors Failed to Oversee, Hold Management Accountable
- Vertex Pharmaceuticals (VRTX) Gets Positive Opinion from CHMP for KALYDECO
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
